Dachaigh › Aillse a' Bhroinn › Texas › San Antonio
Sgrùdaidhean clionaigeach Aillse a' Bhroinn ann an San Antonio, TX
Tha 19 sgrùdaidhean airson Aillse a' Bhroinn a’ lorg phàirtichean aig làraichean ann agus timcheall air San Antonio (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Audie L Murphy VA Hospital, San Antonio
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A’ fastadhÌre 2/3
- Texas Oncology - San Antonio, San Antonio
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology - PARENT, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
A’ fastadhÌre 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- START - San Antonio, San Antonio
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
A’ fastadhÌre 1/2
- South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
A’ fastadhÌre 1
- NEXT San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Research Site, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
A’ fastadhÌre 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- START San Antonio, LLC., San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
A’ fastadhÌre 1
- Dren Investigational Site, San Antonio
Sgrùdaidhean Aillse a' Bhroinn ann am bailtean eile
- Houston, TX42 sgrùdaidhean
- Boston, MA32 sgrùdaidhean
- New York City, NY31 sgrùdaidhean
- Nashville, TN28 sgrùdaidhean
- Baldwin Park, CA22 sgrùdaidhean
- Los Angeles, CA22 sgrùdaidhean
- Arlington, VA20 sgrùdaidhean
- Dallas, TX19 sgrùdaidhean
- St. Louis, MO18 sgrùdaidhean
- Grand Rapids, MI18 sgrùdaidhean
- Washington, DC16 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
Sgrùdaidhean eile ann an San Antonio
- Aillse Sgamhain Neo-chealla-beag59 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Aillse colorectal46 sgrùdaidhean
- Ailse metastatach44 sgrùdaidhean
- Aillse (gach seòrsa)41 sgrùdaidhean
- Obesity40 sgrùdaidhean
- Diabaitis Seòrsa 237 sgrùdaidhean
- Ro-throm34 sgrùdaidhean
- Cancer Ovarian31 sgrùdaidhean
- Cancer Pancreatic31 sgrùdaidhean
- Aillse Prostata28 sgrùdaidhean
- Ailse Endometrial27 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.